- Home
- SWIM vs PSNL Comparison
SWIM vs PSNL Comparison
Compare SWIM & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$6.12
HOLD
Current Price
$6.76
Company Overview
Basic Information| Metric | SWIM | PSNL |
|---|---|---|
| Founded | 1956 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 769.9M | 729.1M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SWIM | PSNL |
|---|---|---|
| Price | $6.12 | $6.76 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $7.33 | ★ $11.50 |
| AVG Volume (30 Days) | ★ 1.5M | 1.4M |
| Earning Date | 06-03-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 160.00 | 33.58 |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $545,912,000.00 | $69,648,000.00 |
| Revenue This Year | $6.64 | $16.94 |
| Revenue Next Year | $5.96 | $36.58 |
| P/E Ratio | $66.89 | ★ N/A |
| Revenue Growth | ★ 7.35 | N/A |
| 52 Week Low | $4.56 | $2.83 |
| 52 Week High | $8.97 | $11.50 |
Technical Indicators
Market Signals| Indicator | SWIM | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 42.18 | 35.07 |
| Support Level | N/A | $4.31 |
| Resistance Level | $7.11 | $6.94 |
| Average True Range (ATR) | 0.45 | 0.70 |
| MACD | -0.07 | -0.20 |
| Stochastic Oscillator | 8.48 | 7.14 |
Price Performance
Historical Comparison SWIM
PSNL
About SWIM Latham Group Inc.
Latham Group Inc is a designer, manufacturer, and marketer of in-ground residential swimming pools, liners, and covers in North America, Australia, and New Zealand. It derives a majority of its revenue from the United States.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.